DNA damage responses at low radiation doses

Radiation Research

Volumn 164, Issue 3, 2005, Pages 292-302

  Short, S C ^a   Bourne, S ^a   Martindale, C ^a   Woodcock, M ^a   Jackson, S P ^b  

^a Gray Cancer Institute   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DNA; DNA DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; KU 55933; NU 7026; PROTEIN P53; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL KILLING; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOSE RESPONSE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING; X RAY;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DIFFERENTIAL THRESHOLD; DNA DAMAGE; DNA, NEOPLASM; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RADIATION DOSAGE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 24144441257     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3421.1     Document Type: Article

References (49)

1. S. Short, C. Mayes, M. Woodcock, H. Johns and M. C. Joiner. Low dose hypersensitivity in the T98G human glioblastoma cell line. Int. J. Radiat. Biol. 75, 847-855 (1999).
2. M. C. Joiner, B. Marples, P. Lambin, S. C. Short and I. Turesson. Low-dose hypersensitivity: Current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 49, 379-389 (2001).
3. M. Krause, M. Joiner and M. Baumann. Ultrafractionation in human malignant glioma xenografts. Int. J. Cancer 107, 333-334 (2003).
4. P. D. Beauchesne, S. Bertrand, R. Branche, S. P. Linke, R. Revel, J. F. Dore and R. M. Pedeux. Human malignant glioma cell lines are sensitive to low radiation doses. Int. J. Cancer 105, 33-40 (2003).
5. J. Harney, N. Shah, S. Short, F. Daley, N. Groom, G. D. Wilson, M. C. Joiner and M. I. Saunders. The evaluation of low dose hyper-radio-sensitivity in normal human skin. Radiother. Oncol. 70, 319-329 (2004).
6. 60Co gamma rays on human tumor cells in vitro. Radiol. Res. 158, 311-318 (2002).
7. J. L. Redpath, S. C. Short, M. Woodcock and P. J. Johnston. Low-dose reduction in transformation frequency compared to unirradiated controls: The role of hyper-radiosensitivily to cell death. Radiat. Res. 159, 433-436 (2003).
8. S. C. Short, M. Woodcock, B. Marples and M. C. Joiner. Effects of ecll cycle phase on low-dose hyper-radiosensitivity. Int. J. Radiat. Biol. 79, 99-105 (2003).
9. 2-phase cells and low-dose hyper-radiosensitivity: A plausible underlying mechanism? Radiat. Res. 160, 38-45 (2003).
10. S. Vaganay-Juery, C. Muller, E. Marangoni, B. Abdulkarim, E. Deutsch, P. Lambin, P. Calsou, F. Eschwege, B. Salles and J. Bourhis. Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br. J. Cancer 83, 514-518 (2000).
11. B. Marples, N. E. Cann, C. R. Mitchell, P. J. Johnston and M. C. Joiner. Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. Int. J. Radiat. Biol. 78, 1139-1147 (2002).
12. K. Skov, B. Marples, J. B. Matthews, M. C. Joiner and H. Zhou. A preliminary investigation into the extent of increased radioresistance or hyper-radiosensitivity in cells of hamster cell lines known to be deficient in DNA repair. Radiat. Res. 138 (Suppl). S126-S129 (1994).
13. K. Rothkamm and M. Lobrieh. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. USA 100, 5057-5062 (2003).
14. 2-M checkpoint activation by histone H2AX and 53BPI Nat. Cell Biol. 4, 993-997 (2002).
15. T. A. Mochan, M. Venere, R. A. Ditullio, Jr. and T. D. Halazonetis, 53BPI and NFBDI/MDCI-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63, 8586-8591 (2003).
16. S. C. Short, S. A. Mitchell, P. Boulton, M. Woodcock and M. C. Joiner. The response of human glioma cell lines to low-dose radiation exposure. Int. J. Radiat. Biol. 75, 1341-1348 (1999).
17. R. E. Durand. Use of a cell sorter for assays of cell clonogenicity. Cancer Res. 46, 2775-2778 (1986).
18. S. J. Veuger, N. J. Curtin, C. J. Richardson, G. C. Smith and B. W. Durkacz. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dcpendent protein kinase and poly(ADP-ribosc) polymerase-1. Cancer Res. 63, 6008-6015 (2003).
19. I. Hickson, Y. Zhao, C. J. Richardson, S. J. Green, N. M. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin and C. G. Smith. Identification and characterisation of a novel and specific inhibitor of the ataxia telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159 (2004).
20. E. P. Rogakou, D. R. Pitch, A. H. Orr, V. S. Ivanova and W. M. Bonner. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (1998).
21. S. Burma, B. P. Chen, M. Murphy, A. Kurimasa and D. J. Chen. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol. Chem. 276, 42462-42467 (2001).
22. T. Stiff, M. O'Driscoll, N. Rief, K. Iwabuchi, M. Lobrich and P. A. Jeggo. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. M. 2390-2396 (2004).
23. J. A. Downs, N. F. Lowndes and S. P. Jackson. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408, 1001-1004 (2001).
24. T. T. Paull, E. P. Rogakou, V. Yamazaki, C. U. Kirchgessner, M. Gellert and W. M. Bonner. A critical role for histone H2AX in recruitment of repair factors to nuclear foci aller DNA damage. Curr. Bipl. 10, 886-895 (20000).
25. A. Celesle, O. Fernandez-Capetillo, M. J. Kruhlak, D. R. Pilch, D. W. Staudt, A. Lee, R. F. Bonner, W. M. Bonner and A. Nussenzweig. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5, 675-679 (2003).
26. A. Celeste, S. Petersen, P. J. Romanienko, O. Fernandez-Capetillo, H. T. Chen, O. A. Sedelnikova, B. Reina-San-Martin, V. Coppola, E. Mcffre and A. Nussenzweig. Genomic instability in mice lacking histone H2AX. Science 296, 922-927 (2002).
27. E. P. Rogakou, C. Boon, C. Redon and W. M. Bonner. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916 (1999).
28. S. H. MaePhail, J. P. Banath, T. Y. Yu, E. H. Chu, H. Lambur and P. L. Olive. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int. J. Radiat. Biol. 79, 351-358 (2003).
29. J. H. Petrini and T. H. Straeker. The cellular response to DNA double-strand breaks: Defining the sensors and mediators. Trends Cell Biol. 13, 458-462 (2003).
30. J. Bakkenist and M. B. Kastan. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003).
31. G. Buscemi, P. Perego, N. Carenini, M. Nakanishi, L. Chessa, J. Chen, K. Khanna and D. Delia. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23, 7691-7700 (2004).
32. K. Rothkamm, I. Kruger, L. H. Thompson and M. Lohrieh. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell Biol. 23, 5706-5715 (2003).
33. I. H. Ismail, S. Martensson, D. Moshinsky, A. Rice, C. Tang, A. Howlelt, G. McMahon and O. Hammarsten. SU11752 inhibits the DNA-dependcnt protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization. Oncogene 23, 873-882 (2004).
34. S. C. West. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4, 435-445 (2003).
35. T. Helleday. Pathways for mitotic homologous recombination in mammalian cells. Mutat. Res. 532, 103-115 (2003).
36. T. Haaf, E. Raderschall, G. Reddy, D. C. Ward, C. M. Radding and E. I. Golub. Sequestration of mammalian Rad51-recombination protein into micronuclei. J. Cell Biol. 144, 11-20 (1999).
37. E. Raderschall, E. I. Golub and T. Haaf. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc. Natl. Acad. Sci. USA 96, 1921-1926 (1999).
38. E. Raderschall, A. Bazarov, J. Cao, R. Lurz, A. Smith, W. Mann, H. H. Ropers, J. M. Sedivy, E. I. Golub and T. Haaf. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J. Cell Sci. 115, 153-164 (2002).
39. L. Pellegrini, D. S. Yu, T. Lo, S. Anaud, M. Lee, T. L. Blundell and A. R. Venkitaraman. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-293 (2002).
40. D. S. Yu, E. Sonoda, S. Takeda, C. L. huang, L. Pellegrini, T. L. Blundell and A. R. Venkitaraman. Dynamic control of Rad51 recombinase by sell-association and interaction with BRCA2. Mol. Cell 12. 1029-1041 (2003).
41. E. Raderschall, K. Stout, S. Freier, V. Suckow, S. Schweiger and T. Haaf. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Rex. 62, 219-225 (2002).
42. W. Henning and H. W. Sturzbeeher. Homologous recombination and cell cycle checkpoints: Rad51 in tumor progression and therapy resistance. Toxicology 193, 91-109 (2003).
43. M. M. Vilenchik and A. G. Knudson. Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer. Proc. Natl. Acad. Sci. USA 100, 12871-12876 (2003).
44. -/- cells. Mutat. Res. 525, 85-92 (2003).
45. F. Daboussi, A. Dumay, F. Delacote and B. S. Lopez, DNA double-strand break repair signalling: The case of RAD51 post-translational regulation. Cell Signal 14, 969-975 (2002).
46. S. P. Linke, S. Sengupta, N. Khahie, B. A. Jeffries, S. Buchhop, S. Miska, W. Henning, R. Pedeux, X. W. Wang and C. C. Harris, px3 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res. 63, 2596-2605 (2003).
47. S. E. Golding, E. Rosenberg, A. Khalil, A. McEwen, M. Holmes, S. Neill, L. F. Povirk and K. Valerie. Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J. Biol. Chem. 279, 15402-15410 (2004).
48. S. Vispe, C. Cazaux, C. Lesca and M. Defais, Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res. 26, 2859-2864 (1998).
49. J. S. Russell, K. Brady, W. E. Burgan, M. A. Cerra, K. A. Oswald, K. Camphausen and P. J. Tofilon. Gleevee-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res. 63, 7377-7383 (2003).